# Wandercraft

> Wandercraft is a French robotics company that builds self-balancing walking exoskeletons and, more recently, industrial humanoid robots. Founded in Paris in 2012 by engineers - some with personal ties to degenerative mobility disease - it created Atalante X, a hands-free clinical exoskeleton now used in more than 100 rehabilitation centers, and Eve, the first self-balancing personal exoskeleton designed for home use without crutches. In 2025 the company extended its gait-control expertise into Calvin, a family of industrial humanoids developed with Renault Group and NVIDIA. Wandercraft's stated aim is to blend frontier AI with high-performance hardware to help people work and walk.

- **Founded:** 2012
- **Headquarters:** Paris, France
- **Founders:** Matthieu Masselin (Co-Founder & CEO), Nicolas Simon (Co-Founder & President), Alexandre Boulanger (Co-Founder), Jean-Louis Constanza (Co-Founder)
- **Team size:** ~150 employees
- **Products:** Atalante X, Eve (Personal Exoskeleton), Calvin-40
- **Notable:** Developed the world's first self-balancing, crutch-free walking exoskeleton, Atalante X deployed in 100+ rehabilitation centers across Europe and the US, Secured multiple FDA indication extensions for Atalante X (SCI C4-L5, stroke, MS)

## Products & services

- **Atalante X** — A self-balancing clinical exoskeleton for hospital and rehabilitation use, enabling hands-free, crutch-free upright gait training. Used in 100+ inpatient and outpatient centers; holds FDA indications for spinal cord injury (C4-L5), stroke/hemiplegia, and multiple sclerosis.
- **Eve (Personal Exoskeleton)** — The first self-balancing personal exoskeleton designed for use at home and outdoors without crutches, supporting standing and walking with a trained companion. In pivotal clinical trials; FDA clearance and market launch anticipated in 2026.
- **Calvin-40** — A voice-controllable industrial humanoid robot built on Wandercraft's exoskeleton platform and NVIDIA Isaac technologies, designed to handle heavy loads and demanding factory tasks. First unit developed in 40 days with Renault Group.

## Achievements

- Developed the world's first self-balancing, crutch-free walking exoskeleton
- Atalante X deployed in 100+ rehabilitation centers across Europe and the US
- Secured multiple FDA indication extensions for Atalante X (SCI C4-L5, stroke, MS)
- Raised ~$170M total, including a $75M Series D in 2025
- Attracted Renault Group as both investor and industrial customer
- Built its first industrial humanoid, Calvin-40, in 40 days using its exoskeleton platform
- Launched a pivotal US clinical trial for Eve, the first personal self-balancing exoskeleton

## Latest updates

- **2025-02** — Launched a pivotal US clinical trial for the Eve personal exoskeleton at the Bronx VA and Kessler Institute.
- **2025-06** — Announced a $75M Series D and a strategic partnership with (and minority investment from) Renault Group.
- **2025-06** — Unveiled Calvin-40, its first industrial humanoid, built in 40 days on NVIDIA Isaac technologies.
- **2025-11** — Received a second FDA indication extension for Atalante X in under two years, adding SCI levels C4-L5 and MS.
- **2026-06** — Named National Seating & Mobility the exclusive US CRT distribution partner for Eve.

## Links

- Website: https://wandercraft.eu
- LinkedIn: https://www.linkedin.com/company/wandercraft
- Twitter/X: https://twitter.com/exowandercraft
- Facebook: https://www.facebook.com/wandercraft.eu/

---

Profile page: https://yespress.io/wandercraft
Published by YesPress — https://yespress.io
Last updated: 2026-07-17